HB 359 - FINAL VERSION
HOUSE BILL 359
SPONSORS: Rep. Loughman, Rock. 21; Rep. Gourgue, Straf. 25; Rep. Josephson, Graf. 11; Rep. Griffith, Hills. 18; Rep. Muscatel, Graf. 12; Sen. Sherman, Dist 24; Sen. Reagan, Dist 17; Sen. Rosenwald, Dist 13
COMMITTEE: Commerce and Consumer Affairs
This bill requires any drug which contains an opiate dispensed by a health care provider or pharmacy to have an orange sticker on the cap or dispenser and a warning label regarding the risks of the drug.
This bill also requires the governor's commission on alcohol and drug abuse prevention, treatment, and recovery to develop a handout on the risks of opioids and how to mitigate them for persons who are receiving prescriptions for opioids.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
05/23/2019 2222s 19-0787
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
Be it Enacted by the Senate and House of Representatives in General Court convened:
318-B:16-a Controlled Drugs Containing Opiates; Warning Label Required. Any controlled drug containing opiates dispensed by a health care provider or pharmacy shall have an orange sticker with the word "opioid" in easily legible font placed on the cap or dispenser and shall have a warning label stating "Risk of addiction and overdose." The health care provider or pharmacist shall also provide each person with a handout which shall be developed and approved by the governor's commission on alcohol and drug abuse, prevention, treatment, and recovery which shall include guidance on associated risks of opioid use and how to mitigate them. This section shall not apply to pharmacists or a pharmacy that dispenses a drug containing an opioid that is administered to a patient treated in a health care facility required to be licensed under RSA 151. A patient may remove the cap sticker or warning label.
VII. Develop a handout which shall describe the risks of opioid use and how to mitigate them for the purposes of RSA 318-B:16-a.
Approved: July 12, 2019
Effective Date: January 01, 2020
|Jan. 2, 2019||Introduced 01/02/2019 and referred to Commerce and Consumer Affairs HJ 2 P. 46|
|Jan. 23, 2019||Public Hearing: 01/23/2019 10:00 am LOB 302|
|Feb. 6, 2019||Subcommittee Work Session: 02/06/2019 09:30 am LOB 104|
|Feb. 6, 2019||Executive Session: 02/06/2019 02:00 pm LOB 302|
|Majority Committee Report: Ought to Pass with Amendment # 2019-0344h (Vote 12-6; RC)|
|March 7, 2019||Majority Committee Report: Ought to Pass with Amendment # 2019-0344h for 03/07/2019 (Vote 12-6; RC) HC 14 P. 7|
|Minority Committee Report: Inexpedient to Legislate|
|March 7, 2019||Amendment # 2019-0344h: AA VV 03/07/2019 HJ 8 P. 9|
|March 7, 2019||Ought to Pass with Amendment 2019-0344h: MA VV 03/07/2019 HJ 8 P. 9|
|March 14, 2019||Introduced 03/14/2019 and Referred to Health and Human Services; SJ 9|
|March 26, 2019||Hearing: 03/26/2019, Room 101, LOB, 02:00 pm; SC 15|
|May 15, 2019||Committee Report: Ought to Pass with Amendment # 2019-1855s, 05/15/2019; SC 22|
|May 23, 2019||Committee Report: Ought to Pass with Amendment # 2019-1855s, 05/23/2019; SC 23|
|May 23, 2019||Special Order to after Executive Departments and Administration, Without Objection, MA; 05/23/2019; SJ 17|
|May 23, 2019||Without Objection, Sen. Feltes Moved the Question, MA; 05/23/2019; SJ 17|
|May 23, 2019||Committee Amendment # 2019-1855s, AF, VV; 05/23/2019; SJ 17|
|May 23, 2019||Sen. Sherman Floor Amendment # 2019-2222s, AA, VV; 05/23/2019; SJ 17|
|May 23, 2019||Ought to Pass with Amendment 2019-2222s, RC 22Y-1N, MA; OT3rdg; 05/23/2019; SJ 17|
|June 13, 2019||House Concurs with Senate Amendment 2222s (Rep. Butler): MA VV 06/13/2019|
|June 27, 2019||Enrolled (In recess 06/27/2019); SJ 21|
|June 27, 2019||Enrolled 06/27/2019|
|Jan. 23, 2019||House||Hearing|
|Feb. 6, 2019||House||Exec Session|
|March 7, 2019||House||Floor Vote|
|March 26, 2019||Senate||Hearing|
|May 15, 2019||Senate||Floor Vote|
|May 23, 2019||Senate||Floor Vote|
|May 23, 2019||Senate||Floor Vote|